Skip to main content

Table 1 Comparison of clinical characteristics among group DOR, NOR and PCOS

From: Effect of PFOA exposure on diminished ovarian reserve and its metabolism

Variables

DOR

NOR

PCOS

DOR vs. NOR p-value

PCOS vs. NOR p-value

Total NO. of patients

25

25

25

  

Age(year)

34.00 ± 3.07

32.08 ± 3.71

29.84 ± 3.93

0.05

0.04

Body mass index(kg/m2)

23.54 ± 4.00

22.82 ± 2.73

23.74 ± 3.95

0.46

0.35

Gravidity

0.96 ± 1.17

0.84 ± 1.14

0.31 ± 0.63

0.72

0.10

Parity

0.36 ± 0.57

0.28 ± 0.42

0.08 ± 0.27

0.30

0.51

Menstrual cycle

30.04 ± 7.14

30.40 ± 7.88

45.28 ± 22.53

0.77

0.00

Primary infertility rate(%)

(12) 48

(13) 52

(18) 72

0.78

0.15

Second infertility rate (%)

(13) 52

(12) 48

(7) 28

  

FSH

9.66 ± 5.20

7.84 ± 2.57

5.76 ± 1.01

0.14

0.00

LH

5.05 ± 2.75

6.10 ± 3.97

8.93 ± 4.79

0.35

0.01

E2

49.59 ± 50.95

36.79 ± 14.37

35.48 ± 18.99

0.83

0.49

AMH

0.57 ± 0.39

1.9 ± 0.57

8.8 ± 4.58

0.00

0.00

IVF(%)

(18) 72

(14) 56

(15) 60

0.38

0.77

ICSI(%)

(7) 28

(11) 44

(10) 4

  

Number of retrieved oocytes

3.48 ± 1.26

9.28 ± 3.92

19.40 ± 6.61

0.00

0.00

  1. NOR Normal ovary response, DOR Diminished ovarian reserve, PCOS Polycystic ovarian syndrome, FSH Follicle-stimulating hormone, LH Luteinizing hormone, E2 17- estradiol, AMH Anti-müllerian hormone, IVF In vitro fertilization, ICSI Intracytoplasmic sperm insemination